L JEFFREY MEDEIROS to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications L JEFFREY MEDEIROS has written about Carcinoma, Non-Small-Cell Lung.
Connection Strength
0.235
-
Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in?situ hybridization. Cancer Cytopathol. 2024 Jan; 132(1):41-49.
Score: 0.068
-
MET Amplification (MET/CEP7 Ratio?= 1.8) Is an Independent Poor Prognostic Marker in Patients With Treatment-naive Non-Small-cell Lung Cancer. Clin Lung Cancer. 2021 07; 22(4):e512-e518.
Score: 0.056
-
Acquired MET amplification in non-small cell lung cancer is highly associated with the exposure of EGFR inhibitors and may not affect patients' outcome. Exp Mol Pathol. 2021 02; 118:104572.
Score: 0.056
-
Low ALK FISH positive metastatic non-small cell lung cancer (NSCLC) patients have shorter progression-free survival after treatment with ALK inhibitors. Cancer Genet. 2020 02; 241:57-60.
Score: 0.052
-
Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases. Mod Pathol. 2000 Jul; 13(7):808-13.
Score: 0.003